RISHON LE ZION, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), an integrator of supply chain technologies for the aerospace, defense, industrial and retail sectors, announced today that it will release financial results for the third quarter of 2026 before the market opens on Monday, November 30, 2026.

Additionally, BOS will host a video conference call on November 30, 2026, at 8:30 a.m. Eastern Time. A question-and-answer session will follow management’s presentation.

To access the video conference meeting, please click on the following link:

https://us06web.zoom.us/j/88403627595?pwd=IvzvcHZooR8CiO7jY4tap56J04OdSQ.1

For those unable to participate in the video conference, a recording of the meeting will be available the next day on the BOS website: www.boscom.com

About BOS

BOS integrates cutting-edge technologies to streamline and enhance supply chain operations for global customers in the aerospace, defense, industrial and retail sectors. The Company operates three specialized divisions:

Supply Chain Division
Distributes and integrates franchised electronic components directly into customer products.

RFID Division
Optimizes customers’ inventory management through state-of-the-art marking and tracking solutions, ensuring real-time visibility and control.

Intelligent Robotics Division
Automates industrial and logistics inventory processes through advanced robotics technologies, improving efficiency and precision.

For more information on BOS Better Online Solutions Ltd., visit www.boscom.com.

Contacts:

Eyal Cohen, CEO
BOS | +972-542525925 | eyalc@boscom.com

Safe Harbor Regarding Forward-Looking Statements

The forward-looking statements contained herein reflect management’s current views with respect to future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties that could cause the actual results to differ materially from those in the forward-looking statements, all of which are difficult to predict and many of which are beyond the control of BOS. These risk factors and uncertainties include, amongst others, the dependency of sales being generated from one or a few major customers, the uncertainty of BOS being able to maintain current gross profit margins, inability to keep up or ahead of technology and to succeed in a highly competitive industry, inability to maintain marketing and distribution arrangements and to expand our overseas markets, uncertainty with respect to the prospects of legal claims against BOS, the effect of exchange rate fluctuations, general worldwide economic conditions, the effect of the ongoing armed conflict and security conditions in Israel and in the region, the continued availability of financing for working capital purposes and to refinance outstanding indebtedness, the risk that a customer order, including the order described herein, may be delayed, modified, or canceled prior to completion of delivery; and additional risks and uncertainties detailed in BOS’ periodic reports and registration statements filed with the US Securities and Exchange Commission. BOS undertakes no obligation to publicly update or revise any such forward-looking statements to reflect any change in its expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

PRESS RELEASE
Paris, 10 September, 2026

Information on the total number of voting rights
and shares forming the share capital

(Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the French Financial Markets Authority)

Date Issued capital Par value Total number of shares Total number of voting rights
Theoretical* Exercisable**
 

August 31, 2026

 

€ 245,607,624 € 1 245,607,624 276,893,345 272,826,627

*In accordance with Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of theoretical voting rights is calculated on the basis of all shares to which voting rights are attached, including shares deprived of voting rights.
**The total number of exercisable voting rights is calculated without taking into account shares deprived of voting rights.


About Valeo

As a technology company and partner to all automakers and new mobility players, Valeo is innovating to make mobility cleaner, safer and smarter. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group’s growth drivers.

Valeo in figures: 20.9 billion euros in sales in 2025 | 100,216 employees, 29 countries, 149 plants, 59 research and development centers, 18 distribution platforms at December 31, 2025.

Valeo is listed on the Paris Stock Exchange.  

Attachment

Transaction in Own Shares

September 09, 2026

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 09 September 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of Purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency
09/09/2026 895,000 £ 35.4500 £ 34.9700 £ 35.2051 LSE GBP
09/09/2026 125,712 £ 35.1100 £ 34.9800 £ 35.0574 Chi-X (CXE) GBP
09/09/2026 – – – – BATS (BXE) GBP
09/09/2026 500,000 € 41.3700 € 40.8500 € 41.1095 XAMS EUR
09/09/2026 – – – – CBOE DXE EUR
09/09/2026 – – – – TQEX EUR

These share purchases form part of the on- and off-market limbs of the Company’s existing share buy-back programme previously announced on 30 July 2026.

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

 

Attachment

INCLINE VILLAGE, Nev.–(BUSINESS WIRE)–Socure, the leading AI-native trust infrastructure for global identity and risk intelligence, today announced it has been chosen by Binance.US, a U.S. digital-asset exchange, to strengthen identity verification, fraud prevention and compliance for customer onboarding. Socure now works with four of the five largest U.S. crypto exchanges, reflecting a broader maturation of the market as organizations invest in the infrastructure required to support trustwor

Visit Gix Internet website: https://www.gix-internet.com/

TEL AVIV, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) — Gix Internet Ltd. (Nasdaq: GIXI; TASE: GIX), a dual-listed technology company, today announced the launch of its new corporate website. The website presents the Company’s strategy of developing one intelligent, AI-powered management and orchestration software layer designed to coordinate an organization’s autonomous robots and the people working alongside them. The goal is to provide one common operating environment for robots, people and autonomous systems. Gix’s wholly owned subsidiary, Deliverz.ai, currently deploys this technology in hospital logistics.

The new website is designed to provide hospitals, potential partners and investors with information regarding the Company’s technology, its current commercial deployment and the Company’s plans for potential expansion into additional markets. Gix’s digital advertising activities are conducted through Quantum X Labs Inc., a separately listed company in which Gix holds a strategic minority interest.

Deliverz.ai assigns, manages and tracks internal deliveries of medications, samples and supplies in real time. It coordinates autonomous robots and human transport teams through a single intelligent management layer and is designed to work with existing hospital infrastructure, including elevators, doors and access control. The platform is robot-agnostic, so hospitals can run a hybrid workforce of machines and people without replacing one for the other. Gix’s broader strategy is to create one intelligent management and orchestration layer for physical operations — connecting robots, people and, over time, additional autonomous systems through one control environment. The Company believes that hospital logistics represents an initial commercial application of the platform and that the technology may ultimately be adaptable to other complex operating environments.

At Sheba Medical Center, ranked among the world’s leading hospitals, Deliverz.ai has been in continuous commercial use since December 2025, and, as of the date hereof, has completed more than 7,000 autonomous missions. In the oncology workflow between the pharmacy and treatment units, the deployment cut chemotherapy delivery time from 40 minutes to 14 minutes. Following a successfully completed pilot, Sheba selected Deliverz.ai under a public tender that provides for the potential deployment of up to 30 robots.

In July 2026, Deliverz.ai announced it was introducing the same approach to healthcare organizations in the United States.

Deliverz.ai holds two granted patents in physical-AI navigation, registered in Israel, Europe and Korea, with applications under review in the United States and Japan.

“Our dual listing on Nasdaq and the Tel Aviv Stock Exchange provides Gix with access to a broader investor audience,” said Amir Nardimon, Chief Executive Officer of Gix Internet. “We believe that the launch of our new website is an important step in presenting our technology, commercial operations and growth strategy more clearly to hospitals, potential partners and investors.”

Nardimon added: “Hospitals manage complex internal logistics involving medications, samples and supplies. Our platform is designed to coordinate autonomous robots and human transport teams through a single operating layer. Building on our commercial deployment at Sheba Medical Center, we are pursuing opportunities to introduce this technology to healthcare organizations in the United States.”

Nardimon continued: “Our vision goes beyond managing an individual robot or automating a single workflow. We are building one intelligent management layer for robots, people and autonomous systems – a common operating environment that can decide what needs to move, who or what should perform the task, and how the operation should be coordinated in real time. Healthcare is where we have first proven this approach commercially, but we believe the same management architecture can ultimately be relevant to many complex physical environments.”

The new website is at: https://www.gix-internet.com/

About Gix Internet Ltd.

Gix Internet Ltd. is listed on the Tel Aviv Stock Exchange and, as of September 1, 2026, on the Nasdaq Capital Market under the symbol GIXI. Its operating focus is Deliverz.ai, a wholly owned company that develops an AI-powered management and orchestration layer for robots, people and autonomous systems, commercially proven today in hospital logistics. The platform combines management software with autonomous mobile robots and human couriers to schedule and assign internal deliveries in real time – by location, priority and availability – from a central operations system. It is built for last-mile movement inside complex, high-traffic facilities such as hospitals, is in commercial use at Sheba Medical Center, and is being introduced to U.S. healthcare organizations. Gix’s broader strategy is to extend the same management architecture to additional autonomous systems and complex physical operating environments. Gix also holds a strategic minority stake in Quantum X Labs Inc., a separately listed company. For more information, visit https://www.gix-internet.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Forward-looking statements contained in this press release include, but are not limited to, statements regarding Gix;s strategic and business plans, technology, relationships, objectives and expectations for its business, growth, the impact of trends on and interest in its business, intellectual property, products and its future results, operations and financial performance and condition and may be identified by the use of words such as “may,” “seek,” “will,” “consider,” “likely,” “assume,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “do not believe,” “aim,” “predict,” “plan,” “project,” “continue,” “potential,” “guidance,” “objective,” “outlook,” “trends,” “future,” “could,” “would,” “should,” “target,” “on track” or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements. For example, the Company is using forward-looking statements when it discusses its strategy of developing and expanding its AI-powered orchestration platform, the potential expansion of its technology into additional markets and operating environments, the anticipated capabilities and benefits of its platform, the potential deployment of additional robots pursuant to the Sheba Medical Center tender, the introduction and commercialization of its technology in the United States, and its growth strategy and future business opportunities. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s registration statement of Form 20-F (File No. 001-43362), as amended, as filed with the SEC on June 18, 2026, and in subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Gix is not responsible for the content of third-party websites.

Investor Relations Contact:

Michal Efraty
Investor Relations
michal@efraty.com

LONDON–(BUSINESS WIRE)–  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.